基于术前CT的Node-RADS评分对胰头癌风险分层：诊断准确性与生存意义
本研究回顾性纳入接受手术切除的胰头腺癌患者，评估术前增强CT的Node-RADS分类对淋巴结转移的诊断效能及预后价值。Node-RADS诊断淋巴结转移的AUC为0.686，敏感度75.0%，特异度62.2%；Node-RADS≥3是全因生存的独立预测因子（HR=2.59，p=0.023）。Node-RADS诊断准确性中等，但可提供独立于常规临床病理因素的预后信息。
要点
- Node-RADS诊断胰头腺癌淋巴结转移的AUC为0.686，敏感度75.0%，特异度62.2%。
- Node-RADS≥3是全因生存的独立预测因子（HR=2.59，p=0.023）。
- 阴性预测值（76.7%）高于阳性预测值（60.0%），提示排除转移价值更优。
核心结论
- Node-RADS对胰头腺癌淋巴结转移具有中等诊断准确性，AUC为0.686。
- Node-RADS≥3是全因生存的独立预测因子，HR为2.59（p=0.023），调整肿瘤分级、淋巴血管侵犯和病理淋巴结状态后仍显著。
- 系统性Node-RADS评分可增强术前风险分层并促进个体化治疗规划。
研究设计与样本
- 回顾性单中心研究，纳入接受手术切除的胰头腺癌患者。
- 术前使用增强CT图像进行Node-RADS分类评估。
- 以ROC分析评估淋巴结转移诊断效能，采用Kaplan-Meier和Cox回归分析生存关联。
诊断标准与关键数值
- Node-RADS诊断淋巴结转移的AUC为0.686，敏感度75.0%，特异度62.2%。
- 阴性预测值为76.7%，阳性预测值为60.0%。
- Node-RADS≥3定义为独立预后不良因素，全因生存风险比HR=2.59（p=0.023）。
临床应用与阅片要点
- 术前CT评估胰头腺癌时，可系统应用Node-RADS评分以辅助淋巴结转移风险判断。
- Node-RADS≥3提示预后较差，可帮助识别高危患者并支持个体化治疗决策。
- Node-RADS阴性预测值较高（76.7%），但阳性预测值较低（60.0%），需结合其他影像征象综合判断。
局限性
- 回顾性单中心研究设计，可能存在选择偏倚。
- Node-RADS诊断淋巴结转移的AUC为0.686，判别能力中等。
以上解读依据论文摘要（全文未开放获取或许可不允许翻译转载）。
英文原文（摘要）· 点击展开
PURPOSE: To evaluate the diagnostic performance and prognostic value of the Node Reporting and Data System (Node-RADS) for predicting lymph node metastasis and survival outcomes in patients with pancreatic head adenocarcinoma.
METHODS: This retrospective single-center study included patients with pancreatic head adenocarcinoma undergoing surgical resection. Preoperative contrast-enhanced CT images were evaluated using the Node-RADS classification. Diagnostic performance for lymph node metastasis was assessed by ROC analysis, and associations with overall and disease-free survival were analyzed using Kaplan-Meier and Cox regression methods.
RESULTS: Node-RADS scoring demonstrated moderate discriminatory ability for detecting lymph node metastasis, with an area under the curve of 0.686, sensitivity of 75.0%, and specificity of 62.2%. The negative predictive value (76.7%) was notably higher than the positive predictive value (60.0%). In multivariate analysis, Node-RADS ≥ 3 emerged as an independent predictor of overall survival (hazard ratio: 2.59, p = 0.023), maintaining significance after adjustment for tumor grade, lymphovascular invasion, and pathologic nodal status.
CONCLUSION: Node-RADS demonstrates moderate diagnostic accuracy for detecting lymph node metastasis in pancreatic head adenocarcinoma but provides independent prognostic information for overall survival beyond conventional clinicopathological factors. Systematic Node-RADS scoring may enhance preoperative risk stratification and facilitate personalized treatment planning in pancreatic cancer patients.
引用
- Parlatan C, Turunç ŞG, Dilek O, et al. Preoperative CT-based node-RADS scoring for risk stratification in pancreatic head cancer: diagnostic accuracy and survival implications. Eur J Radiol. 2026. PMID: 42085768. doi:10.1016/j.ejrad.2026.112895
供执业医师工作参考，不替代临床判断；数值与分级以指南原文为准。